ZA200302636B - Arylpiperazine derivatives and their use as psychotropic agents. - Google Patents
Arylpiperazine derivatives and their use as psychotropic agents. Download PDFInfo
- Publication number
- ZA200302636B ZA200302636B ZA200302636A ZA200302636A ZA200302636B ZA 200302636 B ZA200302636 B ZA 200302636B ZA 200302636 A ZA200302636 A ZA 200302636A ZA 200302636 A ZA200302636 A ZA 200302636A ZA 200302636 B ZA200302636 B ZA 200302636B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- formula
- cha
- solvates
- cehaf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10043659A DE10043659A1 (de) | 2000-09-05 | 2000-09-05 | Arylpiperazinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200302636B true ZA200302636B (en) | 2004-09-08 |
Family
ID=7655009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200302636A ZA200302636B (en) | 2000-09-05 | 2003-04-03 | Arylpiperazine derivatives and their use as psychotropic agents. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040014972A1 (cs) |
| EP (1) | EP1326842A1 (cs) |
| KR (1) | KR20030024913A (cs) |
| CN (1) | CN1452614A (cs) |
| AU (1) | AU2001291744A1 (cs) |
| BR (1) | BR0113581A (cs) |
| CA (1) | CA2421219A1 (cs) |
| CZ (1) | CZ2003809A3 (cs) |
| DE (1) | DE10043659A1 (cs) |
| MX (1) | MXPA03001826A (cs) |
| NO (1) | NO20030998L (cs) |
| PL (1) | PL360289A1 (cs) |
| SK (1) | SK3612003A3 (cs) |
| WO (1) | WO2002020491A1 (cs) |
| ZA (1) | ZA200302636B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE424825T1 (de) | 2001-07-20 | 2009-03-15 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| WO2004082570A2 (en) * | 2003-03-17 | 2004-09-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dopamine receptor d2 (drd2) |
| EP1637530A4 (en) | 2003-06-23 | 2009-04-01 | Dainippon Sumitomo Pharma Co | THERAPEUTIC AGENT FOR SENILE DEMENTIA |
| ES2250000B1 (es) * | 2004-09-29 | 2007-06-01 | Medichem, S.A. | Procedimiento para la preparacion de ziprasidona. |
| ES2250001B1 (es) * | 2004-09-29 | 2007-06-01 | Medichem, S.A. | Proceso para la purificacion de ziprasidona. |
| KR100660142B1 (ko) * | 2005-01-24 | 2006-12-20 | 이명섭 | 건식 모래 생산 방법 및 그 시스템 |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| TW200800959A (en) * | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| TW200808730A (en) * | 2006-06-09 | 2008-02-16 | Wyeth Corp | Process for synthesizing piperazine-piperidine compounds |
| CL2007003410A1 (es) * | 2006-11-28 | 2008-04-11 | Wyeth Corp | Compuestos derivados de 5-fluoro-8-{4-[4-(6-metoxiquinolin-8-il)piperazin-1-il]piperidin-1-il}quinolina; procedimiento de preparacion; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de trast |
| NZ579402A (en) | 2007-03-15 | 2012-03-30 | Novartis Ag | Organic compounds for diagnosis and treatment of pathologies relating to the Hedgehog pathway |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
| WO1998031679A1 (en) * | 1997-01-21 | 1998-07-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Thiophene compounds and medicinal use thereof |
| ES2128266B1 (es) * | 1997-07-08 | 2000-01-16 | Vita Invest Sa | Compuestos derivados de tiofeno y benzotiofeno y utilizacion y composicion correspondientes. |
| EP0900792B1 (en) * | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
-
2000
- 2000-09-05 DE DE10043659A patent/DE10043659A1/de not_active Withdrawn
-
2001
- 2001-08-07 PL PL36028901A patent/PL360289A1/xx unknown
- 2001-08-07 CN CN01815154A patent/CN1452614A/zh active Pending
- 2001-08-07 SK SK361-2003A patent/SK3612003A3/sk unknown
- 2001-08-07 EP EP01971882A patent/EP1326842A1/de not_active Withdrawn
- 2001-08-07 KR KR10-2003-7002743A patent/KR20030024913A/ko not_active Withdrawn
- 2001-08-07 CA CA002421219A patent/CA2421219A1/en not_active Abandoned
- 2001-08-07 MX MXPA03001826A patent/MXPA03001826A/es unknown
- 2001-08-07 WO PCT/EP2001/009108 patent/WO2002020491A1/de not_active Application Discontinuation
- 2001-08-07 CZ CZ2003809A patent/CZ2003809A3/cs unknown
- 2001-08-07 AU AU2001291744A patent/AU2001291744A1/en not_active Abandoned
- 2001-08-07 US US10/363,168 patent/US20040014972A1/en not_active Abandoned
- 2001-08-07 BR BR0113581-3A patent/BR0113581A/pt not_active Application Discontinuation
-
2003
- 2003-03-04 NO NO20030998A patent/NO20030998L/no unknown
- 2003-04-03 ZA ZA200302636A patent/ZA200302636B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03001826A (es) | 2003-06-04 |
| CA2421219A1 (en) | 2003-03-03 |
| DE10043659A1 (de) | 2002-03-14 |
| NO20030998D0 (no) | 2003-03-04 |
| CN1452614A (zh) | 2003-10-29 |
| WO2002020491A1 (de) | 2002-03-14 |
| PL360289A1 (en) | 2004-09-06 |
| KR20030024913A (ko) | 2003-03-26 |
| CZ2003809A3 (cs) | 2003-06-18 |
| AU2001291744A1 (en) | 2002-03-22 |
| SK3612003A3 (en) | 2003-07-01 |
| US20040014972A1 (en) | 2004-01-22 |
| EP1326842A1 (de) | 2003-07-16 |
| NO20030998L (no) | 2003-03-04 |
| BR0113581A (pt) | 2003-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2133152C (en) | Piperidines and piperazines with affinity for 5-ht receptors | |
| JP3834098B2 (ja) | ベンゾニトリル類およびベンゾフルオリド類 | |
| KR100361950B1 (ko) | 3-인돌릴피페리딘 | |
| EP1853602A1 (en) | Chemical compounds | |
| AU2006237920A1 (en) | Nitrogen-containing heterocyclic compound | |
| EP0998474A1 (de) | Piperazin-derivate | |
| ZA200302636B (en) | Arylpiperazine derivatives and their use as psychotropic agents. | |
| CN116600808A (zh) | 一类作为kras突变体g12c抑制剂的四氢萘啶类衍生物、其制备方法及其应用 | |
| US4251538A (en) | Indolealkylamines and processes for their preparation | |
| IE902553A1 (en) | Indole derivatives | |
| DE3421641A1 (de) | Indolderivate | |
| US6333339B1 (en) | 3-Benzylpiperidine | |
| AU2001278457C1 (en) | Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals | |
| EP2736906B1 (en) | N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS | |
| CN116836167B (zh) | 咪唑并[1,2-a]吡嗪或吡唑并[1,5-a]嘧啶衍生物及其用途 | |
| HU194555B (en) | Process for production of new derivatives of indole and medical preparatives containing them | |
| ZA200302255B (en) | Chromenone derivatives and the use thereof for the treatment of diseases in connection with 5-HTA1 receptors and/or dopamine D2 receptors. | |
| HU207069B (en) | Process for producing 3-(3-indolyl)-quinuclidine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| EP1569930B1 (en) | Indol derivatives and their use as 5-ht ligands | |
| JPH03200789A (ja) | ラクタム誘導体の製造法 | |
| JP2006513218A (ja) | インテグリン受容体アンタゴニスト誘導体としてのピラゾール化合物 |